Multiple Yeast Genes, Including Paf1 Complex Genes, Affect Telomere Length via Telomerase RNA Abundance by Mozdy, Amy D et al.
University of Colorado, Boulder
CU Scholar
Chemistry & Biochemistry Faculty Contributions Chemistry & Biochemistry
Summer 6-15-2008
Multiple Yeast Genes, Including Paf1 Complex
Genes, Affect Telomere Length via Telomerase
RNA Abundance
Amy D. Mozdy
University of Utah, amy.mozdy@utah.edu
Elaine R. Podell
University of Colorado Boulder
Thomas R. Cech
University of Colorado Boulder, thomas.cech@colorado.edu
Follow this and additional works at: http://scholar.colorado.edu/chem_facpapers
Part of the Molecular Biology Commons, and the Other Biochemistry, Biophysics, and Structural
Biology Commons
This Article is brought to you for free and open access by Chemistry & Biochemistry at CU Scholar. It has been accepted for inclusion in Chemistry &
Biochemistry Faculty Contributions by an authorized administrator of CU Scholar. For more information, please contact
cuscholaradmin@colorado.edu.
Recommended Citation
Mozdy, Amy D.; Podell, Elaine R.; and Cech, Thomas R., "Multiple Yeast Genes, Including Paf1 Complex Genes, Affect Telomere
Length via Telomerase RNA Abundance" (2008). Chemistry & Biochemistry Faculty Contributions. 18.
http://scholar.colorado.edu/chem_facpapers/18
  Published Ahead of Print 14 April 2008. 
10.1128/MCB.00512-08. 
2008, 28(12):4152. DOI:Mol. Cell. Biol. 
Amy D. Mozdy, Elaine R. Podell and Thomas R. Cech
 
via Telomerase RNA Abundance
Complex Genes, Affect Telomere Length 
Multiple Yeast Genes, Including Paf1
http://mcb.asm.org/content/28/12/4152
Updated information and services can be found at: 
These include:
SUPPLEMENTAL MATERIAL
 Supplemental material
REFERENCES
http://mcb.asm.org/content/28/12/4152#ref-list-1at: 
This article cites 54 articles, 27 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 August 1, 2014 by UNIV O
F CO
LO
RADO
http://m
cb.asm
.org/
D
ow
nloaded from
 
 o
n
 August 1, 2014 by UNIV O
F CO
LO
RADO
http://m
cb.asm
.org/
D
ow
nloaded from
 
MOLECULAR AND CELLULAR BIOLOGY, June 2008, p. 4152–4161 Vol. 28, No. 12
0270-7306/08/$08.000 doi:10.1128/MCB.00512-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Multiple Yeast Genes, Including Paf1 Complex Genes, Affect
Telomere Length via Telomerase RNA Abundance†
Amy D. Mozdy,* Elaine R. Podell, and Thomas R. Cech
Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of Colorado, Boulder,
Colorado 80309-0215
Received 30 March 2008/Accepted 1 April 2008
Twofold reductions in telomerase RNA levels cause telomere shortening in both humans and the yeast Saccha-
romyces cerevisiae. To test whether multiple genes that affect telomere length act by modulating telomerase RNA
abundance, we used real-time reverse transcription-PCR to screen S. cerevisiae deletion strains reported to maintain
shorter or longer telomeres to determine the levels of their telomerase RNA (TLC1) abundance. Of 290 strains
screened, 5 had increased TLC1 levels; 4 of these maintained longer telomeres. Twenty strains had decreased TLC1
levels; 18 of these are known to maintain shorter telomeres. Four strains with decreased TLC1 RNA levels contained
deletions of subunits of Paf1C (polymerase II-associated factor complex). While Paf1C had been implicated in the
transcription of both polyadenylated and nonpolyadenylated RNAs, Paf1C had not been associated previously with
the noncoding telomerase RNA. In Paf1C mutant strains, TLC1 overexpression partially rescues telomere length
and cell growth defects, suggesting that telomerase RNA is a critical direct or indirect Paf1C target. Other factors
newly identified as affecting TLC1 RNA levels include cyclin-dependent kinase, the mediator complex, protein
phosphatase 2A, and ribosomal proteins L13B and S16A. This report establishes that a subset of telomere length
genes act by modulating telomerase RNA abundance.
Telomere length is a quantitative trait affected by more than
273 genes in Saccharomyces cerevisiae (1, 9, 12). To put this
number into perspective, genes representing nearly 5% of the
6,000-gene yeast genome (15) influence telomeres. Some of
these genes directly impact telomere homeostasis, either by
contributing to the activity of the telomerase enzyme or by
affecting the physical state of telomere ends. Most telomere
length genes, however, lack obvious connections to telomere
biology. The functions of these genes include vesicular trans-
port, chromatin modification, ribosome assembly, and tran-
scription. We reasoned that some of the telomere length genes
with unexplained functions may affect telomerase activity by
modulating the abundance of a core telomerase component,
the noncoding telomerase RNA.
The fact that telomerase RNA levels can regulate telomere
length is well established. In humans, dyskeratosis congenita
(28), the bone marrow failure disease, is characterized by short
telomeres resulting from telomerase RNA haploinsufficiency
(11, 26, 27). In yeast studies, we have recently demonstrated a
causal relationship between a twofold reduction in TLC1 (telo-
merase component 1) RNA, resulting from tlc1 heterozy-
gosity, and telomere shortening: ectopic expression of TLC1 in
TLC1/tlc1 cells rescues the telomere length defect (30). The
mechanism of telomere length regulation revealed by telo-
merase RNA haploinsufficiency might be more general. That
is, genes responsible for the transcription, processing, and sta-
bility of the telomerase RNA might influence telomere length.
Two published examples support this hypothesis. Reduc-
tions in TLC1 abundance, caused either by inability of the
RNA to associate with the Sm heteroheptamer or by the
mtr10 mutation, have been correlated with shortened telo-
meres (10, 40). Sm proteins are best known for binding near
the 3 ends and mediating the nuclear localization of small
nuclear RNPs involved in mRNA splicing, so the idea that they
influence telomerase, which is also a noncoding nuclear RNP,
seemed reasonable. Mtr10p was first identified as an importin
required for poly(A) RNA export through its nuclear impor-
tation of Npl3p, an mRNA-binding protein (34).
Given that yeast cells maintain telomerase RNA at a low,
limiting level (30), it seemed likely that regulatory networks
beyond Sm binding and MTR10 exist to modulate the tran-
scription, 3 end formation, and stability of TLC1. To search
for genes in the telomerase RNA biogenesis pathway, we mea-
sured TLC1 RNA abundance in 290 candidate strains. In order
to measure TLC1 RNA with the requisite sensitivity, we used
real-time reverse transcription-PCR (RT-PCR) assays devel-
oped in our laboratory (30). While TLC1-specific oligonucle-
otides have been included on DNA microarrays designed for
high-throughput screening for factors involved in noncoding
RNA biogenesis (35), the steady-state levels of TLC1 were too
low to yield signal above background. In the present study, our
real-time RT-PCR approach was sensitive enough to identify
25 gene deletions (including mtr10) that caused a 1.5-fold or
greater change in telomerase RNA levels. The effect of these
genes could be direct or could be mediated through as-yet-
unidentified intermediates.
This screening uncovered the importance of an RNA poly-
merase II (Pol II)-associated transcriptional complex, called
the Paf1 complex, in TLC1 biogenesis. Approximately 2% of
cellular RNA Pol II is associated with Pol II-associated factor
complex (Paf1C) (31) in complexes that are distinct from Srb-
* Corresponding author. Present address: The Brain Institute at The
University of Utah, 383 Colorow Drive, Room 324, Salt Lake City, UT
84108. Phone: (801) 746-9255. Fax: (801) 585-5375. E-mail: amy.mozdy
@utah.edu.
† Supplemental material for this article may be found at http://mcb
.asm.org/.
 Published ahead of print on 14 April 2008.
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mediator Pol II holoenzymes (42). Paf1C has been shown to
affect 3 end formation of both polyadenylated and nonpoly-
adenylated Pol II transcripts (38), including SDA1 and MAK21
mRNAs (important for ribosome biogenesis) (36) and SNR47,
a noncoding snoRNA (41). TLC1 RNA is transcribed by RNA
Pol II, and a fraction of the RNA is polyadenylated (6). In this
report, we show that cis-acting elements in both the promoter
and the transcribed region of the TLC1 gene respond to Paf1C
to enhance TLC1 RNA accumulation in S. cerevisiae.
Thus, this study identified a set of yeast genes that affect the
steady-state level of TLC1 and are therefore candidates for
being directly involved in TLC1 biogenesis. More generally,
this report contributes to the field of telomere biology by
identifying a previously unappreciated pathway through which
a subset of telomere length genes act: the modulation of
telomerase RNA abundance.
MATERIALS AND METHODS
Real-time RT-PCR screening for altered telomerase RNA abundance. We
selected 290 candidate gene deletion strains from the S. cerevisiae haploid gene
deletion collection (14, 49). The MATa collection was purchased from Open
Biosystems. Candidate strains bud16, ctr9, paf1, set1, sla2, and mtr10
were not included in the MATa collection and were purchased individually or
were purchased as heterozygous diploids and then sporulated. The isogenic
wild-type control strain BY4733 (3) was purchased from ATCC (American Type
Culture Collection; catalog no. 200895).
Deletion strains were grown in yeast extract-peptone-dextrose medium (2%
dextrose) containing 200 g/ml G418. Yeast total RNA was prepared from 108
cells harvested from cultures grown to cell densities between 9 106 and 2 107
cells/ml (as determined by counting with a hemocytometer). The cells were
frozen in liquid nitrogen, stored at 80°C, resuspended in RLT lysis buffer
(Qiagen), and subjected to four rounds of 30 s of glass-bead lysis in a FastPrep
machine (QBiogene). The lysates were processed according to the RNeasy Mini
kit protocol (Qiagen), using an on-column DNase treatment (Qiagen). Total
RNA concentrations were quantified using a NanoDrop-1000 spectrophotome-
ter (NanoDrop) and were serially diluted to 1.25 ng/l into water containing 10
ng/l MS2 carrier RNA (Roche). In vitro-transcribed standard RNAs
TLC1(1261A55), ACT1, and U2 were taken from stocks described previously (30).
The total RNAs and standard RNAs were reverse transcribed as described
previously (30), using the random nonamer/oligo(dT) primer mix provided in a
QuantiTect RT kit (Qiagen). To quantify cDNAs corresponding to total TLC1
[the major poly(A)-negative species and the minor 3-extended poly(A)-positive
species], TLC1 containing the 3 extension, U2, and ACT1, we used our previ-
ously published (30) real-time PCR scorpion assays with primer pairs p38 and
p39, p90 and p91, p34 and p35, and p32 and p33, respectively. Real-time PCRs
were set up essentially as described previously (30), with the following modifi-
cations. The p38-p39 (TLC1), p34-p35 (U2), and p32-p33 (ACT1) 20-l assays
were run simultaneously for each sample in 96-well plates in a LightCycler 480
instrument (Roche). LightCycler 480 probe master mix (Roche) was used for
these real-time PCRs in accordance with Roche’s protocol. The LightCycler 480
cycling parameters were 95°C denaturation for 10 min followed by 45 cycles of
95°C for 10 s, 57°C for 30 s (with a single fluorescence acquisition), and 72°C for
10 s followed by a 50°C cooling period for 10 s. Each 96-well plate contained
samples to create five-point standard curves for TLC1, U2, and ACT1, a no-
template control (water), and duplicate RT reaction mixtures from the wild-type
strain and 12 candidate strains. The p90-p91 (3 extended TLC1) assays were run
in a LightCycler 2.0 instrument as described previously (30).
Real-time RT-PCR data analysis. The TLC1/U2, TLC1/ACT1, and U2/ACT1
ratios listed in Table S1 in the supplemental material were obtained through a
multistep process. First, the absolute quantification module of the LightCycler
480 basic software interpolated the number of TLC1, U2, and ACT1 molecules
present in each PCR based on the internal standard curves, as described previ-
ously (30). These raw values were entered into a database; all the data were
subsequently treated as a single pool rather than as representing discrete 96-well
plates.
Second, the raw TLC1/U2 and TLC1/ACT1 ratios for each sample were
calculated to correct for differences in the input amounts of total RNA in the RT
reaction mixtures. (The U2/ACT1 ratio was also calculated as a way to flag
samples whose U2 or ACT1 abundance noticeably differed from that of the wild
type.) More than one real-time RT-PCR was performed for each candidate. The
ratios are listed in Table S1 in the supplemental material.
Third, the ratios for each candidate were normalized against the relevant
wild-type ratios. These final numbers (shown in the Fig. 1 histograms) facilitate
quick assessment of how different the telomerase RNA levels in each candidate
deletion strain are from those of the wild type.
Yeast strains and plasmids. Strains denoted BY were S288C descendants (3),
and strains denoted JJ were derived from D273-10b (46). Full genotypes of the
following JJ strains were published previously (2): JJ662 (wild type), JJ665
(cdc73), JJ1328 (ctr9), JJ576 (paf1), JJ1336 (leo1), JJ1303 (rtf1), JJ1202
(paf1 ctr9), JJ1361 (paf1 leo1), and JJ1326 (paf1 rtf1). The pTLC1
plasmid (see Fig. 3) used in this study was pRS426-TLC1.
The luciferase reporter strains (see Fig. 4) were generated in two steps. First,
the promoter for vector pJJ1358TLC1 was made by cloning the TLC1 promoter
into the KpnI site of the luciferase reporter integrating vector pJJ1358 (36). We
assumed the TLC1 promoter sequences were contained within the 252-bp intergenic
region between the closest upstream gene (SNR161) and TLC1. This promoter
region was amplified with AMp166 (5-GGGGTACCTCTAGAACTTGTGTTAG
TTTATAAATAAATTTTATATCACTATATGTGTGG) and AMp167 (5-GGG
GTACCTAGTTTTATTCTCAAACCAGAAAAATCACACTAAAAGCTAC).
The full sequence of the promoter for pJJ1358TLC1 is available upon request.
Second, the integrating vector was cleaved at the unique NcoI site within the
URA3 marker and transformed into JJ662 (wild type) and JJ665 (cdc73).
Integrants were selected on synthetic media lacking uracil. End-point PCR was
used to verify that the TLC1-promoter–luciferase-reporter cassette had inte-
grated at the URA3 locus (the primers used were AMp180 [5-CACATGCAG
CTCCCGGAGACGGTCACAGCTTGTC] and AMp185 [5-GTTACTTGGTT
CTGGCGAGGTATTGGATAGTTCC]). Note that we generated luciferase
FIG. 1. Distribution of TLC1 levels in 290 candidate deletion
strains. For each strain listed in Table S1 in the supplemental material,
the mean ratios of TLC1/U2 (panel A) and TLC1/ACT1 (panel B),
normalized to the relevant wild-type (WT) mean ratio, were grouped
into bins and plotted as a histogram. U2 is an snRNA (small nuclear
RNA involved in mRNA splicing), and ACT1 is the actin mRNA. For
comparison, measurements of the wild-type ratios from five inde-
pendent RNA preparations are shown (dark cross-hatched bars).
The sensitivity of ACT1 mRNA levels to cell density (30) may
contribute to the spread in the TLC1/ACT1 ratios. A Gaussian
distribution (black curve) was fitted to each histogram. The param-
eters of the Gaussian fits are mean  0.986, standard deviation 
0.274, and R2  0.979 (A) and mean  0.992, standard deviation 
0.342, and R2  0.909 (B).
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reporter strains only in the JJ background; the BY strain background is ura30
and completely lacks a URA3 sequence into which the cassette could integrate.
The tetO7 promoter-TLC1 strain was constructed in two steps. First, we
generated a PCR cassette to replace the 50 nucleotides upstream of the TLC1
coding sequence with the Kanr-tetO7-TATACYC1 heterologous promoter by use
of AMp101 (5-CATTGACATTTTCATAGGGTACCTATCTTCCTCTCTAG
TTTTATTggatcccccgaattgatc), AMp102 (5-AAAACTTCCTCTTTAGCAATG
GTGACATATAGATCTCAAGGTTCTagcggataacaatttcacacagga), and the
plasmid containing RP188, the Kanr-tetO7-TATACYC1 template (21). (Note that
the uppercase primer sequences correspond to TLC1 sequence and the lower-
case to the promoter cassette amplified from RP188.) Second, this PCR cassette
was integrated into the TLC1 locus in strain R1158 (21). (R1158 contains the
tTA transactivator integrated into the same BY MATa strain used in the genome
deletion collection.) Colony-purified G418-resistant colonies were confirmed by
PCR. TLC1 expression from the tetO7 promoter was effectively shut off in the
presence of 10 g/ml doxycycline, as verified by Northern blot analysis and
real-time RT-PCR.
To generate the tetO7 promoter-TLC1 cdc73 strain, the tetO7 promoter-
TLC1 strain was crossed to the BY cdc73 strain and the resulting diploid was
sporulated. The spores were genotyped both by PCR, for detection of the
presence of the tetO7 and cdc73 alleles, and by growth on plates lacking uracil,
to select for strains containing the tTA transactivator, which is essential for tetO7
promoter activity.
Luciferase mRNA quantification. Because TLC1 RNA is present in low abun-
dance in cells (30), we reasoned that the TLC1 promoter may be too weak to
drive sufficient luciferase expression for luminescence measurements. Instead,
we monitored luciferase mRNA expression directly by real-time RT-PCR. The
luciferase reporter strains (CDC73 TLC1 promoter-luciferase and cdc73 TLC1
promoter-luciferase) were grown to log phase and harvested. Total RNA was
extracted, diluted, and reverse-transcribed, as described previously (30). The
cDNA was amplified using the following luciferase-specific scorpion primer/
probe set (designed by DxS Limited and synthesized by Biosearch Technologies):
AMp164 (5-F-CCGCGCTATGAAACGATATGGGCGCGG-Q-B-GCATAC
GACGATTCTGTGATTTGTA, where F is 6-carboxyfluorescein, Q is Black
Hole Quencher 1, and B is hexaethylene glycol), and AMp165 (5-ACGTACG
CGGAATACTTCGAA). This primer set produced a 90-bp PCR product, which
was measured in the LightCycler 480 instrument as described above. To deter-
mine the efficiency of the real-time PCR luciferase assay, we generated a five-
point standard curve by use of 10-fold serial dilutions of luciferase control RNA
purchased from Promega (catalog no. L4561); this Coleoptera luciferase mRNA
corresponds to the sequence of Promega’s pGEM-luc vector. Both the reaction
efficiency (1.94) and the error (0.007) indicated a robust assay.
Initial measurements of 12 independent isolates from luciferase reporter
strains revealed various luciferase mRNA levels, in multiples of the lowest
observed number, suggesting that some of the strains contained more than one
luciferase reporter cassette. To test this, we generated a standard curve using
linearized pJJ1358TLC1 promoter plasmid and measured luciferase copy num-
bers in the genomic DNA prepared from the 12 strains. Five showed multiple
(two to four) integrations, which correlated with the observed mRNA expression
results. To verify that these strains had multiple integrations, we designed an
end-point PCR assay, using AMp180 (5-CACATGCAGCTCCCGGAGACGG
TCACAGCTTGTC) and AMp181 (5-GGTTCACGTAGTGGGCCATCGCC
CTGATAGACGG), that amplified a product only when head-to-tail copies of
the luciferase cassette were present. A PCR product was generated for all the
suspected multiple-integrant strains and none for the single-integrant strains. We
used the single-integrant strains for the analyses (see Fig. 4B).
Northern and Southern blot analyses. Northern and Southern blot analyses
were performed as described previously (53). Relative changes in telomere
length were measured using ImageQuant TL.
RESULTS
Selection of gene deletion strains. The 290 candidate strains
were selected by the following criteria: (i) 273 strains had been
found to have altered telomere lengths in large-scale telomere
length screenings (1, 12); (ii) 11 had been reported to have a
clumpy cell morphology (49) similar to that of the observed
microscopic phenotype of tlc1 cells (A. D. Mozdy and T. R.
Cech, unpublished data); (iii) 5 had been found to show dele-
tions of genes that interact with the Paf1 complex and were
added during the study, after we identified the importance of
the Paf1 complex; and (iv) 1 (mtr10) had been previously
shown to have short telomeres because of reduced TLC1 levels
(10) and therefore served as a positive control.
A subset of telomere length genes affects telomerase RNA
abundance. We measured telomerase RNA (TLC1) levels in
290 nonessential gene deletion strains by using real-time RT-
PCR assays we had described previously (30). Five indepen-
dent RNA preparations from wild-type cells showed similar
TLC1/U2 RNA ratios (Fig. 1A) but more variability in their
TLC1/ACT1 RNA ratios (Fig. 1B), suggesting that some of the
spread observed for the deletion strains was due to experimen-
tal variability. We therefore required that a strain have both
TLC1/U2 and TLC1/ACT1 ratios that differed from those of
the wild type by at least 1.5-fold in order to be scored as having
a significantly different TLC1 RNA level; the 25 strains that
met this standard are listed in Table 1. This conservative cri-
terion excludes candidates whose TLC1 count appears altered
relative to the presence of only one normalizer (either U2 or
ACT1). While such candidates may indeed impact TLC1, we
erred on the stringent side to limit false positives arising from
genes that instead affect U2 or ACT1 RNAs. For example, the
TLC1/U2 ratio in the lea1 strain is twofold higher than in
wild-type cells (the TLC1/ACT1 ratio indicates a lesser, 1.3-
fold effect). Lea1p is a component of the U2 snRNP and is
necessary for normal accumulation of U2 (44). The inflated
TLC1/U2 ratio in lea1 cells is therefore at least partially due
to depressed U2 levels. The TLC1/U2, TLC1/ACT1, and U2/
ACT1 ratios for all 290 strains can be found in Table S1 in the
supplemental material.
As is consistent with observations that telomerase abun-
dance influences telomere length (8, 30), 18 of the 20 deletion
strains that contained less TLC1 than wild type are known to
have short telomeres, while 4 of the 5 deletion strains that
contained more TLC1 than wild type had long telomeres (Ta-
ble 1). Of the 290 candidate strains, deletion of MTR10 had the
largest impact (an approximately sevenfold decrease) on te-
lomerase RNA abundance. Because Mtr10p is an importin
that is already known to contribute to TLC1 RNA levels (10,
30), its appearance in Table 1 provides some validation of our
screening.
The next largest effects (greater than twofold decreases)
were observed with cdc73, ctr9, paf1, and leo1 cells. The
products of these four genes physically and functionally inter-
act within Paf1C (31). In addition to exhibiting reduced overall
levels of TLC1, the Paf1C mutant strains contain altered levels
of the 3-extended form of TLC1 relative to the mature form
(Table 1). Because the screening unambiguously revealed the
importance of the Paf1 complex in TLC1 biogenesis, we fo-
cused the remainder of this study on Paf1C. The other hits are
addressed in the Discussion.
The Paf1 complex is required for telomerase RNA to accu-
mulate to wild-type levels. The Paf1C is comprised of Cdc73p,
Ctr9p, Paf1p, Leo1p, and Rtf1p (31). Four of the five subunits
were identified in the real-time RT-PCR screening as altering
the TLC1/U2 and TLC1/ACT1 ratios by at least 1.5-fold; the
rtf1 strain missed the cutoff for inclusion in Table 1 because
its TLC1/ACT1 ratio was 1.4-fold lower than that of the wild
type. To further explore the role of the Paf1 complex in TLC1
transcription/stability, we examined TLC1 RNA from strains
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lacking each of the five subunits in two genetic backgrounds
(BY strains and JJ strains). Both real-time RT-PCR and
Northern blot analyses indicated that TLC1 is reduced approx-
imately fourfold in strains lacking Cdc73p, Paf1p, or Ctr9p,
and approximately twofold in strains lacking Leo1p or Rtf1p,
in both backgrounds (Fig. 2A, B, and D). This two- to fourfold
drop in TLC1 RNA levels was consistent with the pattern
reported for other Paf1C transcriptional targets in paf1 cells
(5). The TLC1 transcripts appeared to be similar to the wild
type in size, although reduced in abundance (Fig. 2D). The
U2/ACT1 ratios were not depressed in the Paf1C mutants (Fig.
2C), demonstrating that the Paf1 complex does not affect all
noncoding RNAs transcribed by Pol II.
We measured TLC1 in paf1 leo1 and paf1 rtf1 double
mutants (Fig. 2B), because leo1 and rtf1 mutations have
been reported to suppress paf1 phenotypes such as slow
growth, temperature sensitivity, and decreased expression of
several Paf1C transcriptional targets (31). For example, the
level of mRNA of CLN1, the G1 cyclin, is reduced threefold in
paf1 cells but is restored to wild-type levels in paf1 rtf1
double mutants (31). In contrast, neither the loss of Leo1 nor
the loss of Rtf1 suppressed the low TLC1 levels observed in
TABLE 1. Telomere length genes that affect telomerase RNA levels by at least 1.5-fold
Gene
Open
reading
frame
Gene ontology
annotation
Telomere
phenotype
(reduction)a
Telomere
phenotype
reference(s)
Ratio normalized against WTb
No. of RNA
preparations
TLC1
transcripts
WT in sizec
TLC1/
U2
TLC1/
ACT1
3-extended
TLC1/total
TLC1
MTR10 YOR160W hnRNP import into
nucleus
Short 10 0.15 0.23 2.33 1 NDd
CDC73 YLR418C Transcription, Paf1
complex
Short (160 bp) This study (1, 12) 0.20 0.25 2.14 4 Yes
CTR9 YOL145C Transcription, Paf1
complex
Short (170 bp) This study 0.25 0.35 1.57 3 Yes
PAF1 YBR279W Transcription, Paf1
complex
Short (110 bp) This study (12) 0.25 0.38 1.91 4 Yes
LEO1 YOR123C Transcription, Paf1
complex
Short (110 bp) This study (12) 0.40 0.43 2.12 4 Yes
NUT3 YBL093C Transcription, mediator
complex
Short (140 bp) This study 0.43 0.59 1.16 3 Yes
ARF1 YDL192W Vesicular transport Slightly short 12 0.48 0.54 1.65 2 ND
YKU70 YMR284W Telomerase RNP Very short 1, 12 0.53 0.67 1.61 2 Yes
TPD3 YAL016W Protein phosphatase
type 2A regulator
Short 1 0.54 0.60 0.72 2 ND
RPL13B YMR142C Ribosome biogenesis/
assembly
Slightly short 1, 12 0.55 0.64 0.88 2 Yes
HUR1 YGL168W DNA replication Short (75 bp) This study (1) 0.56 0.59 0.64 3 Yes
VPS34 YLR240W Vesicular transport Short 1, 12 0.56 0.65 0.70 2 ND
AGP2 YBR132C Amino acid transport Short 1 0.57 0.55 1.03 2 Yes
ARV1 YLR242C Vesicular transport and
sterol metabolism
Short 1 0.59 0.63 0.90 2 ND
UGO1 YDR470C Mitochondrion Slightly long 1 0.59 0.57 0.75 2 ND
SMI1 YGR229C Cell wall organization/
biogenesis
Short 1 0.59 0.59 1.05 2 ND
HDA2 YDR295C Transcription, histone
deacetylation
Short 1 0.61 0.63 1.26 2 ND
HFI1 YPL254W Transcription, SAGA
complex adaptor
Short (120 bp) This study (12) 0.61 0.63 1.38 3 ND
CWP2 YKL096W-A Cell wall organization/
biogenesis
ND 0.62 0.58 1.85 2 Yes
PHO85 YPL031C Signal transduction
kinase
Short 1 0.65 0.64 1.16 2 ND
RPS16A YMR143W Ribosome biogenesis/
assembly
Slightly long 1, 12 1.54 1.66 0.84 2 Yese
SRB2 YHR041C Transcription, mediator
complex
Slightly short 1, 12 1.65 1.78 0.35 1 ND
ARD1 YHR013C Protein acetylation Very long 12 1.90 1.58 ND 1 ND
PPE1 YHR075C Protein phosphatase
2A methylesterase
Long 1 1.93 1.55 ND 1 ND
REF2f YDR195W RNA 3-end processing Slightly long 12 1.44 2.75 1.77 3 Yes
a Telomere length classifications follow those in previous reports (1, 12): slightly short (	50 bp shorter than WT), short (50 to 200 bp shorter than WT), very short
(
150 bp shorter than WT), slightly long (	50 bp longer than WT), long (50 to 300 bp longer than WT), and very long (
150 bp longer than WT). Note that some
categories overlap because the reported telomere length categories differ (1, 12). For telomeres examined in this study, specific telomere length reductions are indicated
in parentheses.
b The mean ratio for each gene deletion strain was normalized against the relevant mean wild-type (WT) ratio (the ratio for TLC1/U2 is 0.0406, for TLC1/ACT1
is 0.155, and for TLC1–3 ext/total TLC1 is 0.160).
c TLC1 transcripts were examined by Northern blot analysis. Two major TLC1 transcripts are visible in total RNA isolated from wild-type cells: a 1.157-kb mature
form and a larger, polyadenylated, 3 extended form.
d ND, not determined.
e The mature, 1.157-kb TLC1 transcript is present in cells lacking Rps16Ap; however, the 3 extended form is not discernible by Northern analysis.
f The ref2 strain does not fit the strict criterion that both the TLC1/U2 and TLC1/ACT1 ratios must differ from that of the WT by at least 1.5-fold. It is included
in this table because of all the strains examined, telomerase RNA levels in this strain are the most dramatically increased. The normalized U2/ACT1 ratio (1.9) indicates
that U2 snRNA levels in ref2 cells are also elevated, which could account for the observed TLC1/U2 ratio.
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paf1 cells (Fig. 2B; see results for paf1 leo1 and paf1 rtf1
double mutants). Instead, we found that paf1 is epistatic to
leo1 with respect to TLC1 abundance. The difference be-
tween leo1 cells and paf1 leo1 cells in TLC1 levels is
statistically significant (P 	 0.05 using a Student’s t test). (The
difference between rtf1 and paf1 rtf1 cells in TLC1 levels is
not statistically significant [P  0.07].)
As is consistent with the most dramatic reductions in TLC1
RNA, telomeres were shortest in cdc73, paf1, and ctr9
cells in both the BY and JJ backgrounds (Fig. 2E). A subtle
difference between BY and JJ backgrounds for the leo1 and
rtf1 strains was observed: TLC1 levels were more depressed
in leo1 than in rtf1 BY cells, while the opposite was observed
for JJ cells.
More telomerase RNA partially rescues the telomere length
and growth defects in Paf1C mutant cells. Cells lacking Paf1C
components have shortened telomeres and reduced TLC1
RNA levels. To test whether insufficient telomerase RNA is
responsible for the telomere length defect, we expressed TLC1
from a high-copy plasmid in Paf1C mutant strains. Because
TLC1 RNA expressed from its endogenous promoter fails to
accumulate to wild-type levels in Paf1C mutants, we measured
TLC1 RNA by real-time RT-PCR to see whether high-copy-
number plasmid expression could boost steady-state TLC1 lev-
els. As shown at the bottom of Fig. 3A (TLC1/ACT1 ratios),
Paf1C mutant strains expressing the high-copy TLC1 plasmid
contained at least 10-fold more TLC1 RNA than the Paf1C
strains carrying an empty plasmid and at least 3-fold more
TLC1 RNA than wild-type cells. This excess TLC1 RNA was
processed normally; the 3 extended/total TLC1 ratios were
indistinguishable between cdc73 cells expressing endogenous
and high-copy plasmid levels of TLC1 (data not shown). After
fewer than 50 generations posttransformation with the high-
copy-number TLC1 plasmid, telomeres were markedly length-
ened in cdc73 and ctr9 cells and slightly lengthened in paf1
cells (Fig. 3A). Telomeres were also slightly lengthened in
leo1 cells from the BY background but slightly shortened in
those from the JJ background.
It seemed possible that TLC1 overexpression might cause
general telomere lengthening, even in short-telomere strains
that do not have reduced telomerase RNA levels. We there-
fore tested three strains with normal TLC1 levels (see Table S1
in the supplemental material): dcc1, vps28, and upf3. In
addition to the data reported here, previous double-mutant
FIG. 2. The Paf1 complex is necessary for wild-type telomerase RNA accumulation and telomere maintenance. (A, B, and C) TLC1, U2, and
ACT1 RNA levels were measured by real-time RT-PCR and normalized as indicated. At least three independent RNA preparations were analyzed
for each strain shown, except for the JJ paf1 strain, where n  2. Error bars represent the standard errors of the means. TLC1 levels in each
deletion strain were compared to TLC1 levels in the isogenic wild-type (WT) strain by use of a Student’s two-tailed t test (, P 	 0.05; , P 	
0.001). The bracket in panel B indicates a significant difference between leo1 cells and paf1 leo1 cells in TLC1 abundance levels. (D) The same
RNA samples were analyzed by Northern blotting; both the 3 extended and mature forms of TLC1 are indicated by the bracket. (E) To assess
telomere length in the Paf1C mutant strains, genomic DNA was prepared and analyzed via Southern blotting. A change in telomere length relative
to wild-type results is indicated. Hybridization to a chromosome IV (Chr IV) restriction fragment serves as an internal length standard and a
loading control. Note that the XhoI digest patterns differ between the non-Y telomeres of the BY and the JJ strain backgrounds. *, insufficient
genomic DNA to measure telomere fragment length due to poor viability of the JJ paf1 strain.
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analyses of dcc1 tlc1, vps28 tlc1, and upf3 tlc1 indi-
cated that the effects of these genes on telomere length were
not exclusively dependent on the presence of telomerase (12).
While TLC1 overexpression had subtle effects on telomere
lengths in dcc1, vps28, and upf3 cells (Fig. 3B), the lack of
a clear gain in telomere length as observed in cdc73 and ctr9
cells after the same generation time suggested that excess
telomerase RNA does not generally impact short telomeres in
fewer than 50 generations. The rescue of short telomeres in
cdc73 and ctr9 cells, then, is likely due to reversing the cause
of the short telomeres, i.e., to insufficient TLC1 RNA levels.
The observed partial, rather than complete, restoration of
telomeres to wild-type length may be explained by the short
generation time. If we were to passage these cells through
more generations, telomeres might fully recover. To avoid
ambiguities in interpretation, given the observation that TLC1
overexpression for 250 generations causes telomere lengthen-
ing in wild-type cells (30), presumably via an adaptive cellular
FIG. 3. Ectopic expression of telomerase RNA partially rescues the telomere length and growth defects of Paf1C mutant cells. (A) Telomeres
in cells containing either an empty high-copy-number (2m) plasmid (lanes with no plasmid indicated) or a 2m plasmid expressing TLC1
(pTLC1) were analyzed by Southern blotting. The changes in telomere length caused by increasing TLC1 RNA levels are indicated, as are TLC1
levels relative to ACT1 mRNA levels. Chr IV, chromosome IV. (B) Telomeres in strains (BY background) lacking telomere length maintenance
genes that affect telomerase-independent pathway(s) were analyzed by Southern blotting. These strains contained either an empty 2m plasmid
or a 2m plasmid expressing TLC1 (pTLC1). The changes in telomere length relative to wild type (WT) are indicated (diagonal numbers),
as are the changes in telomere length between cells expressing an empty 2m plasmid and pTLC1 (horizontal numbers). (C) Overexpressing
TLC1 partially rescues the temperature sensitivity of Paf1C mutants in the JJ strain background. The same strains from which DNA was
harvested for the Southern blot shown in panel A were grown to late log phase and suspended at a concentration of 108 cells/ml. Serial
dilutions (100-fold; 108, 106, and 104 cells/ml) were then spotted on plates and incubated at either 30°C or 37°C. p-empty, empty
high-copy-number (2m) plasmid.
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process that responds to increased steady-state TLC1 levels
over time, we did not track telomere length beyond 50 gener-
ations. Instead, we looked for quick and dramatic telomere
lengthening in a restricted time frame during which the telo-
meres of wild-type cells are unaffected by increased telomerase
RNA.
We noticed that Paf1C mutant strains containing the high-
copy-number TLC1 plasmid grew better in liquid culture than
the same strains containing an empty plasmid. To examine this
growth phenotype more closely, we spotted serially diluted
cells onto plates and grew them at 30°C and 37°C (Fig. 3C). As
previously reported, the cdc73, ctr9, paf1, and rtf1 muta-
tions caused temperature sensitivity in the JJ background (2).
This temperature sensitivity phenotype was partially rescued
by TLC1 overexpression (Fig. 3C, top right panel). Paf1C mu-
tants in the BY background were not as sensitive to high
temperature (Fig. 3C, bottom panels). This observation raises
the possibility that temperature sensitivity is related to telo-
mere length, because telomeres are shorter in the JJ Paf1C
mutants than in the BY Paf1C mutants (Fig. 2E). Another
possibility is that increased telomerase RNA affects the levels
or functions of associated proteins that impact temperature
sensitivity. A practical outcome of the observation that excess
telomerase RNA can partially rescue telomere length and
growth defects of Paf1C mutants is that growing difficult Paf1C
mutant strains can be augmented by transforming these cells
with a high-copy-number TLC1 plasmid.
Paf1C has both promoter-dependent and promoter-inde-
pendent effects on telomerase RNA. Although the Paf1 com-
plex accompanies Pol II for all transcriptionally active yeast
genes (32), its loss affects only a small subset of transcripts
(36). At least some of these targets rely on Paf1C for posttran-
scriptional processing (36, 41) but not for initiation, raising the
following question: is Paf1C required at the promoter (e.g., for
initiation of TLC1 transcription) or for downstream events,
which could include transcript elongation and 3 end forma-
tion? To address this question, we performed two sets of ex-
periments. First, we tested the sensitivity of the TLC1 pro-
moter to the cdc73 mutation by use of a luciferase reporter.
Second, we tested the sensitivity of the TLC1 transcribed re-
gion to cdc73 by use of a heterologous promoter driving
TLC1 expression.
We measured accumulation of telomerase RNA and lucif-
erase mRNA, both driven by the TLC1 promoter, in CDC73
and cdc73 strains. As expected, telomerase RNA levels were
reduced nearly fourfold in cdc73 cells compared to CDC73
cell results (Fig. 4A, left bars). There was also less luciferase
mRNA in cdc73 cells than in CDC73 cells, although the effect
was smaller (a 1.6-fold reduction) (Fig. 4A, right bars). A
Student’s t test revealed this 1.6-fold difference to be significant
(P 	 0.001). This depression in luciferase mRNA production
was not due to an effect of cdc73 on the luciferase transcript
itself; when a luciferase construct lacking the TLC1 promoter
was integrated into the URA3 locus so that luciferase transcrip-
tion was driven from the nearest promoter element, luciferase
mRNA accumulated to the same low level in CDC73 and
cdc73 strains (data not shown). This reporter analysis indi-
cated that Paf1C is required for normal transcription from the
TLC1 promoter but that this promoter effect alone is too small
to account for the observed reduction of TLC1 RNA levels in
cdc73 cells.
To examine the effect of cdc73 on the transcribed TLC1
region, we replaced the endogenous TLC1 promoter with a
heterologous promoter, tetO7 (29). We then measured TLC1
RNA levels in the following four isogenic strains: CDC73
TLC1 promoter-TLC1, cdc73 TLC1 promoter-TLC1, CDC73
TetO7 promoter-TLC1, and cdc73 TetO7promoter-TLC1.
TLC1 RNA accumulated to approximately sixfold-higher lev-
els when expressed from the tetO7 promoter compared to the
results seen with its endogenous promoter (Fig. 4B). The im-
portant comparison (between CDC73 tetO7 promoter-TLC1
cells and cdc73 tetO7 promoter-TLC1 cells) revealed a two-
fold decrease in TLC1 RNA levels upon loss of Cdc73p (Fig.
4B, right bars). These data indicated that the Paf1 complex
also plays a promoter-independent role in TLC1 biogenesis.
The decrease in TLC1 levels observed in cdc73 cells, then, is
multiplicative: an approximately twofold promoter-dependent
role and a twofold promoter-independent role for Paf1C ac-
count for the approximately fourfold total effect on TLC1
RNA accumulation.
FIG. 4. The Paf1 complex affects both promoter-dependent and
promoter-independent aspects of TLC1 RNA accumulation. (A) Loss
of Cdc73p affects luciferase mRNA production from the TLC1 pro-
moter. Total RNA was extracted from CDC73 and cdc73 strains
expressing the TLC1 promoter-luciferase reporter and was reverse
transcribed. TLC1 RNA and luciferase mRNA levels were then quan-
tified by real-time RT-PCR and normalized to the same internal ACT1
mRNA measurement. Each bar represents the mean of the results
obtained with four independent RNA preparations; the error bars
represent standard errors of the means. (B) Loss of Cdc73p affects
TLC1 expression, even when driven from a heterologous promoter.
Total RNA was extracted from CDC73 and cdc73 strains expressing
TLC1 either from its endogenous TLC1 promoter or from the heter-
ologous TetO7 promoter and was reverse transcribed. TLC1 RNA was
then quantified by real-time RT-PCR and normalized to ACT1 mRNA
levels. (The same results were obtained when TLC1 was normalized to
U2 snRNA levels; data not shown.) Each bar represents the mean of
the results obtained with at least four independent RNA preparations;
the error bars represent standard errors of the means.
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DISCUSSION
Overview of the telomerase RNA abundance screening. Our
real-time RT-PCR screening identified 24 genes not known
previously to affect TLC1 steady-state abundance and repli-
cated the finding (10) that MTR10 affects TLC1 biogenesis.
These genes affect diverse biological functions (Table 1). The
most-represented function is transcription; we found four
members of the Pol II-associated complex Paf1C (CDC73,
CTR9, PAF1, and LEO1), two members of the Pol II-associ-
ated mediator complex (NUT3 and SRB2), and two genes that
modulate the histone acetylation state (HDA2 and HFI1).
These gene products could be directly involved in TLC1 RNA
transcription or they could affect the expression of an interme-
diary protein that contributes to TLC1 RNA accumulation.
The functional breakdown of the remaining genes is as follows:
(i) vesicular transport (ARF1, VPS34, and ARV1); (ii) RNA
processing (MTR10 and REF2); (iii) protein phosphatase 2A
activity (TPD3 and PPE1); (iv) telomerase RNP production
(YKU70); (v) signal transduction (PHO85); (vi) ribosome bio-
genesis (RPL13B and RPS16A); and (vii) genes whose broad
biological functions are unclear (HUR1, AGP2, UGO1, SMI1,
CWP2, and ARD1).
Because the screening identified multiple members of the
Paf1 complex, we used the Osprey network visualization tool
(4) to look for other interactions between the genes listed in
Table 1. The following pairs interact genetically: genes SMI1
and PHO85 (synthetic lethality) (25, 45); genes PHO85 and
HFI1 (synthetic lethality) (20, 24); genes HFI1 and NUT3,
genes SRB2 and ARD1, and genes ARD1 and HUR1 (pheno-
typic suppression) (7); genes HUR1 and YKU70, genes YKU70
and CDC73, and genes ARD1 and CDC73 (phenotypic en-
hancement) (7); and genes PPE1 and TPD3 (synthetic rescue)
(19). This final pair is interesting, because tpd3 cells contain
decreased telomerase RNA and short telomeres whereas
ppe1 cells contain increased telomerase RNA and long telo-
meres. The opposing effects make sense in light of the oppos-
ing functions of Ppe1p and Tpd3p, both of which regulate
protein phosphatase 2A activity. Protein phosphatase 2A ac-
tivity is decreased in tpd3 cells and increased in ppe1 cells
(19); this observation, in conjunction with our analysis, indi-
cates that protein phosphatase 2A activity leads to increased
transcription or stability of telomerase RNA. It will be inter-
esting to test whether other protein phosphatase 2A holoen-
zyme components (RRD2, PPH21, CDC55, and PPM1) affect
telomerase RNA levels and/or telomere length.
NUT3 and SRB2 interact physically (13) within the mediator
complex. Yeast mediator is a 25-protein complex that regulates
Pol II transcriptional initiation (22). Of the 15 nonessential me-
diator components, 12 (NUT3, SRB5, SOH1, NUT1, GAL11,
MED1, PGD1, SRB2, SRB8, SRB9, SRB10, and SRB11) are re-
ported to affect telomere length (1, 12). These 12 define com-
ponents of the head, middle, tail, and cyclin-dependent kinase
(CDK) mediator modules (16). The CDK module is a negative
regulatory module (17) that represses transcription of 3% of
the yeast genome (18). Deletion of any of the four CDK com-
ponents (SRB8 to SRB11) results in long telomeres and ele-
vated levels of telomerase RNA (see Table S1 in the supple-
mental material). The subtle (	1.5-fold) increases in TLC1
levels observed by real-time PCR were confirmed by Northern
analysis (data not shown), suggesting that TLC1 is a novel
target of CDK repression. On the other hand, loss of NUT3,
the head component, leads to a twofold drop in TLC1 levels
(Table 1). Altogether, our data suggest that mediator is im-
portant for TLC1 transcription but that its effect is negatively
regulated by the CDK module.
Three of the genes listed in Table 1, CTR9, NUT3, and
CWP2, were not previously known to affect telomerase and
telomeres. This is not surprising, given that the published ge-
nome-wide screenings for telomere length defects were esti-
mated to have missed 40% of genes that affect telomere
length (9). We analyzed ctr9 cells because the Paf1C is clearly
important for TLC1 accumulation. We analyzed nut3 and
cwp2 cells solely because their clumpy cell morphology is
reminiscent of the tlc1 phenotype we observed (Mozdy and
Cech, unpublished). We do not know whether or how telo-
merase RNA levels are linked to cellular morphology; how-
ever, clumpiness was either a reasonable or a fortuitous crite-
rion for inclusion in our screening because it led to the
identification of two additional genes that affect telomerase
RNA levels.
The Paf1 complex affects promoter-dependent and promot-
er-independent steps of TLC1 production. This study revealed
that the Paf1 complex is important for TLC1 biogenesis, with
quantitatively similar effects on the transcribed region of
the gene (observed with a heterologous promoter) and on the
DNA sequences preceding the start site for transcription—the
putative promoter. We were unable to test whether these ef-
fects are direct or indirect using either of two obvious ap-
proaches: use of directed mutations of Paf1C-responsive cis
elements within TLC1 or use of a PAF1 conditional allele.
First, no significant consensus sequence larger than 4 bp has
been identified in the promoters of the Paf1C primary target
genes (36), so it is unclear what element(s) in the TLC1 pro-
moter the Paf1C might recognize. In addition, no common
elements in the 3 untranslated regions of Paf1 targets been
identified (36). Second, the long half-life of TLC1 precludes
distinguishing direct from indirect effects in a time course
following shutoff of a conditional PAF1 allele. TLC1’s half-life
has been reported to exceed 1 h (23) and to be at least 2 h (6).
To conclude that a transcript is a direct Paf1C target, a previ-
ous study required that the transcript undergo a twofold
change in expression over a 2-h time period following shutoff
of a tetracycline-regulated PAF1 (36). By the time (2 h) a
twofold change could be detected in TLC1 abundance, other
shorter-lived transcripts would have been affected, obfuscating
interpretation.
For the remainder of this discussion, we assume that the
TLC1 gene is the direct target of Paf1C, although we do not
discount the possibility that Paf1C regulates production of
other factors that in turn interact with the promoter region and
the transcribed region of TLC1. Even with this assumption, the
mechanism of the Paf1C effect is complicated to address, be-
cause the Paf1 complex has been implicated in all stages of Pol
II transcription, from initiation to elongation to 3 end forma-
tion. Cdc73p forms a stoichiometric complex with Pol II (42),
and Paf1C components are found at promoters and through-
out the coding regions of genes (37, 43). The Paf1C interacts
with elongation complexes that modify chromatin via histone
methylation and ubiquitination (33, 48, 50, 51) and with 3 end
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formation complexes, including the THO component of the
transcription export complex (5) and Nrd1p and Nab3p, the
snoRNA terminators (41). Although many of these Paf1C in-
teraction partners (BRE1, BRE2, CCR4, CDH1, CTK1, HPR1,
MFT1, RAD6, SET1, SPT4, and THP2) were included in this
screening, none appeared to impact TLC1 RNA levels as much
as Paf1C did. While it is intriguing that the THO complex
members HPR1, MFT1, and THP2 have subtle but clear effects
on TLC1 levels (see Table S1 in the supplemental material),
this observation is insufficient to suggest that RNA export is
the critical step in the Paf1C-guided journey to TLC1 RNA
maturation.
For many of the known Paf1C transcriptional targets, the
critical Paf1C role was shown to be promoter-independent,
posttranscriptional processing (36, 41). Specifically, Paf1C is
important for the proper utilization of a subset of poly(A) sites;
loss of the Paf1C leads to reduced utilization of proximal
poly(A) sites and increased utilization of distal poly(A) sites
for primary target genes SDA1 and MAK21 (36). TLC1 RNA is
unusual in having both poly(A) and poly(A) forms and in
having an A-U-rich 3 region with multiple candidate polyad-
enylation sites (6). Decreased utilization of a major TLC1
poly(A) site in Paf1C mutants could partially account for re-
duced TLC1 RNA. The published U1221G mutation in a
TLC1 polyadenylation efficiency element (nucleotides 1221 to
1226) (6) leads to a 1.4-fold reduction in the predominant,
mature form of TLC1 (1.157 kb long), a greater than three-
fold reduction in the less-abundant, 3-extended, polyadeny-
lated form (1.35 kb long), and the appearance of a larger
transcript that is visible on a Northern blot but is too faint to
be quantified (Mozdy and Cech, unpublished). Although no
discrete elongated TLC1 species was discernible by Northern
blot analysis in total RNA extracted from paf1C mutant
strains, there was a clear increase in the ratio of 3-extended
TLC1 to total TLC1 in the absence of Paf1C (Table 1). The
observation that a TLC1 cis element predicted to guide poly-
adenylation enhances both TLC1 accumulation and proper 3
end formation gives plausibility to a model in which the Paf1C
enhances utilization of TLC1 polyadenylation signals that gen-
erate a stable RNA.
However, there are also reasons to believe that the role of
Paf1C in TLC1 transcription may be more complex. First, no
aberrant 3 ends were observed for TLC1 transcripts isolated
from Paf1C mutant cells (Fig. 2D), in contrast to previous
results for other Paf1C targets (36, 41). Second, TLC1 RNA
analysis results deviate from the short half-life pattern of other
primary targets that exhibit decreased abundance upon loss of
Paf1 (36). The average yeast mRNA half-life is 21 min (18,
47), while the average mRNA half-life of a primary Paf1C
target whose level is depressed upon loss of Paf1 is 12 min (36).
The half-life of TLC1 is over an hour (23). Third, unlike other
primary Paf1C targets which are relatively unaffected by the
cdc73 mutation (5), reduction of TLC1 levels was more ex-
tensive in cdc73 cells than in any other Paf1C mutant. Cdc73p
anchors the rest of the Paf1C to Pol II and chromatin (32), so
the fact that its loss has a large effect on TLC1 levels suggests
that Paf1C may function in TLC1 promoter-dependent initia-
tion.
The human homolog of CDC73, HRPT2 (hyperparathy-
roidism-jaw tumor syndrome 2), has been implicated in human
cancers (39, 52, 54). It will be interesting to determine whether
telomerase RNA levels are affected in tumors harboring mu-
tant HRPT2.
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